Chinese drugmaker Clover says vaccine prevents COVID-19 in large trial

Cover picture for the articleChinese drugmaker Clover Biopharmaceuticals said Wednesday its experimental coronavirus vaccine prevented COVID-19 in a large Phase 3 trial, reporting efficacy of 67% against disease of any severity and 85% against moderate-to-severe disease. Clover is preparing to seek conditional authorization with global regulatory agencies in the fourth quarter and is...

Comments / 3

Comments / 0